Literature DB >> 30691384

Satisfaction and Needs in Serious Mental Illness and Autism Spectrum Disorder: The REHABase Psychosocial Rehabilitation Project.

Nicolas Franck1, Laura Bon1, Marie Dekerle1, Julien Plasse1, Catherine Massoubre1, Romain Pommier1, Emilie Legros-Lafarge1, Nemat Jaafari1, Nathalie Guillard-Bouhet1, Clélia Quilès1, Geoffroy Couhet1, Hélène Verdoux1, Benjamin Gouache1, Brice Martin1, Sophie Cervello1, Caroline Demily1, Julien Dubreucq1.   

Abstract

OBJECTIVE: The REHABase project is a French observational, prospective, and multicenter cohort study of serious mental illness and autism spectrum disorder (ASD), launched in 2016 for a planned minimum duration of 15 years. The aim is to characterize the care and quality-of-life needs of participants. This article presents initial results from data collection.
METHODS: Psychosocial, cognitive, and functional data were collected at baseline, annually, and after rehabilitation care. Data from the baseline evaluation on diagnoses, medications, well-being, insight, life satisfaction, and care needs are presented. The clinical profiles of REHABase participants with serious mental illness or ASD were assessed in relation to their level of satisfaction with life and well-being in nine life dimensions and their needs, according to their stage of recovery in a five-stage model.
RESULTS: Baseline data were collected for 1,397 participants between January 2016 and August 2018. Main diagnoses were schizophrenia spectrum disorder (49%); ASD (13%); and personality (12%), bipolar (9%), and major depressive (6%) disorders. More than 50% of participants reported needs for care or interventions in four of nine dimensions: employment, cognitive functioning, symptom management, and interpersonal relationships. Nearly half of participants were not in the active stages of recovery (stages 4 and 5), and even those considered to have reached the final stage continued to require help in several areas.
CONCLUSIONS: Most participants had already received psychiatric care for several years, and most remained dissatisfied with their social and emotional life and their psychological well-being.

Entities:  

Keywords:  Quality of life; Recovery; Rehabilitation/psychosocial

Mesh:

Year:  2019        PMID: 30691384     DOI: 10.1176/appi.ps.201800420

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  8 in total

1.  Characteristics associated with self-reported medication adherence in persons with psychosis referred to psychosocial rehabilitation centers.

Authors:  Hélène Verdoux; Clélia Quiles; Laura Bon; Isabelle Chéreau-Boudet; Julien Dubreucq; Emilie Legros-Lafarge; Nathalie Guillard-Bouhet; Catherine Massoubre; Julien Plasse; Nicolas Franck
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-11-10       Impact factor: 5.270

2.  Self-stigma in Serious Mental Illness: A Systematic Review of Frequency, Correlates, and Consequences.

Authors:  Julien Dubreucq; Julien Plasse; Nicolas Franck
Journal:  Schizophr Bull       Date:  2021-08-21       Impact factor: 9.306

3.  Improving social function with real-world social-cognitive remediation in schizophrenia: Results from the RemedRugby quasi-experimental trial.

Authors:  Julien Dubreucq; Franck Gabayet; Bernard Ycart; Megane Faraldo; Fanny Melis; Thierry Lucas; Benjamin Arnaud; Mickael Bacconnier; Motassem Bakri; Gentiane Cambier; Florian Carmona; Isabelle Chereau; Titaua Challe; Sophie Morel; Sylvie Pires; Celine Roussel; Philippe Lamy; Guillaume Legrand; Emmanuelle Pages; Romain Pommier; Romain Rey; Yohan Souchet; Pierre-Michel Llorca; Catherine Massoubre
Journal:  Eur Psychiatry       Date:  2020-04-30       Impact factor: 5.361

4.  Narrative enhancement and cognitive therapy (NECT) to improve social functioning in people with serious mental illness: study protocol for a stepped-wedge cluster randomized controlled trial.

Authors:  J Dubreucq; M Faraldo; M Abbes; B Ycart; H Richard-Lepouriel; S Favre; F Jermann; J Attal; M Bakri; T Cohen; C Cervello; I Chereau; C Cognard; M De Clercq; A Douasbin; J Y Giordana; E Giraud-Baro; N Guillard-Bouhet; E Legros-Lafarge; M Polosan; A Pouchon; M Rolland; N Rainteau; C Roussel; C Wangermez; P T Yanos; P H Lysaker; N Franck
Journal:  Trials       Date:  2021-02-08       Impact factor: 2.279

5.  The central role of self-esteem in the quality of life of patients with mental disorders.

Authors:  Guillaume Barbalat; Julien Plasse; Emmanuel Gauthier; Hélène Verdoux; Clélia Quiles; Julien Dubreucq; Emilie Legros-Lafarge; Nematollah Jaafari; Catherine Massoubre; Nathalie Guillard-Bouhet; Frédéric Haesebaert; Nicolas Franck
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.996

6.  Cognitive deficits in children with autism spectrum disorders: Toward an integrative approach combining social and non-social cognition.

Authors:  Melek Hajri; Zeineb Abbes; Houda Ben Yahia; Selima Jelili; Soumeyya Halayem; Ali Mrabet; Asma Bouden
Journal:  Front Psychiatry       Date:  2022-08-08       Impact factor: 5.435

7.  Actionable Predictive Factors of Homelessness in a Psychiatric Population: Results from the REHABase Cohort Using a Machine Learning Approach.

Authors:  Guillaume Lio; Malek Ghazzai; Frédéric Haesebaert; Julien Dubreucq; Hélène Verdoux; Clélia Quiles; Nemat Jaafari; Isabelle Chéreau-Boudet; Emilie Legros-Lafarge; Nathalie Guillard-Bouhet; Catherine Massoubre; Benjamin Gouache; Julien Plasse; Guillaume Barbalat; Nicolas Franck; Caroline Demily
Journal:  Int J Environ Res Public Health       Date:  2022-09-27       Impact factor: 4.614

8.  Self-stigma in serious mental illness and autism spectrum disorder: Results from the REHABase national psychiatric rehabilitation cohort.

Authors:  J Dubreucq; J Plasse; F Gabayet; M Faraldo; O Blanc; I Chereau; S Cervello; G Couhet; C Demily; N Guillard-Bouhet; B Gouache; N Jaafari; G Legrand; E Legros-Lafarge; R Pommier; C Quilès; D Straub; H Verdoux; F Vignaga; C Massoubre; N Franck
Journal:  Eur Psychiatry       Date:  2020-02-07       Impact factor: 5.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.